| Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838) |
|---|
| 06/01/2006 | WO2006057629A1 Agent for prophylaxis and treatment of a human reproductive system disorders filomek and method for the production thereof |
| 06/01/2006 | WO2006057289A1 Novel shuttle vector |
| 06/01/2006 | WO2006057278A1 Remedy for heart disease using map kinase tnni3k |
| 06/01/2006 | WO2006056823A1 Modulating retinal pigmented epithelium permeation by inhibiting or activating vegfr-1 |
| 06/01/2006 | WO2006056306A2 Hydrogel polymeric conjugates of a prodrug |
| 06/01/2006 | WO2006056061A1 Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| 06/01/2006 | WO2006031467A9 Isolated lineage negative hematopoietic stem cells and methods of treatment therewith |
| 06/01/2006 | WO2006020958A3 Organogenesis from dissociated cells |
| 06/01/2006 | WO2006019300A3 Immune stimulatory infant nutrition |
| 06/01/2006 | WO2006014468A3 Saif, an anti-inflammatory factor, and methods of use thereof |
| 06/01/2006 | WO2006012615A3 Lysine citrate for plasma protein and donor protection |
| 06/01/2006 | WO2005097974A3 Method for the production of a cell composition containing epithelial cells |
| 06/01/2006 | WO2005093047A3 3d-cardiac tissue engineering for the cell therapy of heart failure |
| 06/01/2006 | WO2005012492A8 Human skin equivalents expressing exogenous polypeptides |
| 06/01/2006 | US20060115538 Calcium lactate and whey permeate for lowering the triglyceride level |
| 06/01/2006 | US20060115511 Porous structures, and methods of use |
| 06/01/2006 | US20060115466 Reducing of undesired side reactions upon treating a red blood cell composition with a pathogen inactivating compound comprising a nucleic acid binding ligand and an electrophilic group |
| 06/01/2006 | US20060115463 Composition of fibroblast or chondrocyte cells transfected or transduced with a gene encoding transforming growth factor beta 1 (TGF- beta 1) or bone morphogenetic protein 2 (BMP-2), and chondrocyte cells that have not been transfected with the gene; generating hyaline cartilage at a target site |
| 06/01/2006 | US20060115459 Sickle cell anemia treatment |
| 06/01/2006 | US20060115458 Material for repairing biological tissues, product for repairing biological tissues, and method of manufacturing material for repairing biological tissues |
| 06/01/2006 | DE4216878B4 Medizinische Vorrichtung mit erhöhter Biokompatibilität und Verfahren zum Erhöhen der Biokompatibilität von Polymeroberflächen einer medizinischen Vorrichtung mittels Radiofrequenzplasma A medical device with improved biocompatibility, and methods for increasing the biocompatibility of polymeric surfaces of a medical device by means of radio frequency plasma |
| 06/01/2006 | DE102004057171A1 Verwendung von Trimethylarsin als Verbindung mit organoleptischen Eigenschaften Using trimethyl as a compound with organoleptic properties |
| 06/01/2006 | CA2589279A1 Methods to identify, prepare, and use naive t cell recent thymic emigrants |
| 06/01/2006 | CA2586126A1 Novel shuttle vector |
| 06/01/2006 | CA2527750A1 A dried product and a process for manufacturing the product |
| 05/31/2006 | EP1662004A1 Method of efficiently constructing growth regulatory recombinant adenovirus vector and kit for the construction thereof |
| 05/31/2006 | EP1662003A2 Paramyxovirus vector for gene transfer to the cardiovascular system |
| 05/31/2006 | EP1661984A1 Method of differentiation from embryo-stem cell of primate to hematogenous cell |
| 05/31/2006 | EP1661983A1 Lactic acid bacteria having mucosal immunopotentiation effect |
| 05/31/2006 | EP1661982A1 Novel lactobacillus, living body activating lactobacillus preparation and preventive or therapeutic agent against living body infection |
| 05/31/2006 | EP1661972A1 Method for extracting lipophilic elements from aqueous substrates |
| 05/31/2006 | EP1661574A1 Beta-hydroxy short to medium chain fatty acid polymer |
| 05/31/2006 | EP1660644A1 Kidney derived stem cells and methods for their isolation, differentiation and use |
| 05/31/2006 | EP1660643A1 Method of repairing primate mammalian tissue |
| 05/31/2006 | EP1660642A1 Methods of preparing a transplantable product for treatment of skin defects |
| 05/31/2006 | EP1660633A2 Entrapped stem cells and uses thereof |
| 05/31/2006 | EP1660632A2 Human skin equivalents expressing exogenous polypeptides |
| 05/31/2006 | EP1660118A2 Method for identification of tr1 lymphocytes regulators by the presence and overexpression of specific molecules and application thereof |
| 05/31/2006 | EP1660105A1 Method of replenishing cells damaged by treatment for cancer |
| 05/31/2006 | EP1659979A1 Three-dimentional tissue structure |
| 05/31/2006 | EP1659885A1 Compositions and methods for the maintenance of oral health |
| 05/31/2006 | EP1333845A4 Treatment of t cell disorders |
| 05/31/2006 | EP1301228A4 Deployment system for myocardial cellular material |
| 05/31/2006 | EP1285057B1 Isolation of mesenchymal stem cells and use thereof |
| 05/31/2006 | EP1268798B1 Anti-angiogenic properties of vascostatin and fragments or variants thereof |
| 05/31/2006 | EP1246789B1 Methods of making optically pure (r)- and (s)- didesmethylsibutramine |
| 05/31/2006 | EP1221957B1 Method for preparing a composition by mother-of-pearl extraction,and use thereof in cosmetics and dermatology |
| 05/31/2006 | EP1198580B1 Scleroprotein of an adeno-associated virus with modified chromatographic properties, the production thereof and use of the same |
| 05/31/2006 | EP1171454B1 Chimeric lyssavirus nucleic acids and polypeptides |
| 05/31/2006 | EP1090136B1 Mumbaistatin, a process for its production and its use as a pharmaceutical |
| 05/31/2006 | EP0888456B1 Prostate specific antigen oligo-epitope peptide |
| 05/31/2006 | EP0796338B1 Encapsidation cell lines for the transcomplementation of defective retroviral vectors |
| 05/31/2006 | EP0757717B1 Papillomavirus vaccines |
| 05/31/2006 | EP0689593B1 Inhibition of selected tumor growth with recombinant viral vector |
| 05/31/2006 | CN1780636A Combined use of G-CSF with angiogenetic factor |
| 05/31/2006 | CN1780632A Therapy for primary and metastatic cancers |
| 05/31/2006 | CN1780557A Improving health and/or nutritional status of an aquatic animal by aid of bacillus licheniformis |
| 05/31/2006 | CN1780556A Treating hepatocellular carcinomas using therapeutic viruses |
| 05/31/2006 | CN1778384A Prescription from Chinese angelica for treating involutional syndrome |
| 05/31/2006 | CN1778382A Rupikang and its preparation |
| 05/31/2006 | CN1778379A Compound pearl grass oral liquid |
| 05/31/2006 | CN1778377A Chinese medicine for treating hypertension emergency |
| 05/31/2006 | CN1778376A Medicine composition for lowering blood fat |
| 05/31/2006 | CN1778375A Chinese medicine for treating chronic bronchitis |
| 05/31/2006 | CN1778374A Externally-applied Chinese medicine for treating acute and chronic pharyngolaryn gitis and its therapeutic belt thereof |
| 05/31/2006 | CN1778368A Chinese medicine composition for treating bone disease, its preparation and use thereof |
| 05/31/2006 | CN1778367A Rapid-acting meridian ease pain cream and preparation thereof |
| 05/31/2006 | CN1778358A Medicine for treating prostatic accrementition and its preparation |
| 05/31/2006 | CN1778357A Medicine for treating urine retention of prostate and its preparation |
| 05/31/2006 | CN1778356A Rehabilitation powder for paralysis |
| 05/31/2006 | CN1778329A Medicine for treating hydrophobia and its process thereof |
| 05/31/2006 | CN1778325A Disperse tablet for activating bood and stopping pain and its preparation |
| 05/31/2006 | CN1778317A Antibiotic companion for degradating bacterial drug resistance |
| 05/31/2006 | CN1778316A Degradation of bacterial drug resistance by composite microbial preparation |
| 05/31/2006 | CN1778315A Eijknisia flower honey and oral liquid |
| 05/31/2006 | CN1778314A Health-care medical wine for tonifying kidney-yang |
| 05/31/2006 | CN1257747C Medicinal liquor for treating rheumatism |
| 05/31/2006 | CN1257743C Composite gastrodia luber medicine and its preparation and use |
| 05/31/2006 | CN1257742C Nourishing medicinal wine |
| 05/31/2006 | CN1257741C Badger fat hair-growth promoting ointment and its preparation method |
| 05/31/2006 | CN1257739C Senshitong mixture |
| 05/31/2006 | CN1257737C Chinese traditional medicinal composition for treating hemicrania and its preparing process |
| 05/31/2006 | CN1257732C Medicine for treating mastosis and preparation process thereof |
| 05/31/2006 | CN1257731C Pollen and medicinal composition for cosmetics and its preparation |
| 05/31/2006 | CN1257724C Composition for preventing and treating diabets mellitus |
| 05/31/2006 | CN1257720C Capsule of Chinese traditional medicine for treating thrombus |
| 05/30/2006 | US7053187 Sperm-specific monoclonal antibody, mAbC |
| 05/30/2006 | US7053062 Compositions and methods for inducing gene expression |
| 05/30/2006 | US7053042 Activation of peptide prodrugs by hK2 |
| 05/30/2006 | US7052909 activation of natural killer T-lymphocytes(NKT) using phosphatidylinositol mannoside(PIM); prophylaxis of skin disorders, cancers or tuberculosis |
| 05/30/2006 | US7052907 Adult human dental pulp stem cells in vitro and in vivo |
| 05/30/2006 | US7052896 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 05/30/2006 | US7052832 Determining sensitivity of a cell to reovirus infection; obtain cells, monitor ras protein signaling, consistent signaling indicates sensitivity to reovirus infection |
| 05/30/2006 | US7052829 Prevascularized constructs for implantation to provide blood perfusion |
| 05/30/2006 | US7052721 Recovery of compounds using a natural adsorbent |
| 05/30/2006 | US7052720 Spheroid preparation |
| 05/30/2006 | US7052716 Cosmetic and dermatological preparations comprising an effective content of bile acids, their salts and/or their derivatives |
| 05/30/2006 | US7052715 Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
| 05/30/2006 | US7052690 by isolating a mammalian conjunctival tissue explant in a growth medium until nodules form, then allowing cells to grow; for treating lacerated corneas, ocular cicatricial pemphigoid, Steven Johnson syndrome, alkali burns and neurotrophic keratitis; kits for detecting mucin deficiency |
| 05/30/2006 | US7052689 Preventing viral replication in cells; obtain cells, incubate with viricide, monitor cells for reduced viral activity |